盐酸考来维仑和碳酸镧会干扰左甲状腺素的吸收。 - Suppr

Suppr

超能文献

Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine.

作者信息

Weitzman Steven P, Ginsburg Karyn C, Carlson Harold E

出版信息

Thyroid. 2009 Jan;19(1):77-9. doi: 10.1089/thy.2008.0312.

DOI:10.1089/thy.2008.0312

PMID:19119983

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2858370/

Abstract

摘要

相似文献

Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine.

Thyroid. 2009 Jan;19(1):77-9. doi: 10.1089/thy.2008.0312.

Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide.

J Clin Pharmacol. 2010 May;50(5):554-65. doi: 10.1177/0091270009349378. Epub 2009 Sep 29.

Colesevelam. GT 31104, CholestaGel.

Drugs R D. 1999 Jun;1(6):479-80. doi: 10.2165/00126839-199901060-00013.

Drug interactions with colesevelam hydrochloride, a novel, potent lipid-lowering agent.

Cardiovasc Drugs Ther. 2000 Dec;14(6):681-90. doi: 10.1023/a:1007831418308.

Colesevelam for the management of type 2 diabetes.

Expert Opin Drug Metab Toxicol. 2009 Feb;5(2):187-94. doi: 10.1517/17425250802709009.

Colesevelam hydrochloride powder for oral suspension versus cholestyramine powder for oral suspension: comparison of acceptability and tolerability.

Endocr Pract. 2011 Mar-Apr;17(2):218-25. doi: 10.4158/EP10251.OR.

Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin.

Diabetes Res Clin Pract. 2014 Jun;104(3):401-9. doi: 10.1016/j.diabres.2013.12.033. Epub 2014 Jan 14.

[Colesevelam hydrochloride. A product description].

Ugeskr Laeger. 2005 Mar 14;167(11):1271-3.

Colesevelam: a review of its use in hypercholesterolemia.

Am J Cardiovasc Drugs. 2007;7(6):453-65. doi: 10.2165/00129784-200707060-00009.

The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study.

Metab Syndr Relat Disord. 2010 Apr;8(2):179-88. doi: 10.1089/met.2009.0049.

引用本文的文献

Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.

Ther Clin Risk Manag. 2023 Jun 23;19:503-523. doi: 10.2147/TCRM.S414460. eCollection 2023.

A critical review of Roxadustat formulations, solid state studies, and analytical methodology.

Heliyon. 2023 Jun 1;9(6):e16595. doi: 10.1016/j.heliyon.2023.e16595. eCollection 2023 Jun.

Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption.

Front Endocrinol (Lausanne). 2022 Dec 6;13:1080108. doi: 10.3389/fendo.2022.1080108. eCollection 2022.

Levothyroxine: Conventional and Novel Drug Delivery Formulations.

Endocr Rev. 2023 May 8;44(3):393-416. doi: 10.1210/endrev/bnac030.

Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.

Rev Endocr Metab Disord. 2022 Jun;23(3):463-483. doi: 10.1007/s11154-021-09691-9. Epub 2021 Oct 20.

A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Eur Endocrinol. 2013 Mar;9(1):40-47. doi: 10.17925/EE.2013.09.01.40. Epub 2013 Mar 15.

Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature.

BMC Nephrol. 2018 Jul 2;19(1):155. doi: 10.1186/s12882-018-0947-9.

Concurrent Milk Ingestion Decreases Absorption of Levothyroxine.

Thyroid. 2018 Apr;28(4):454-457. doi: 10.1089/thy.2017.0428. Epub 2018 Mar 28.

Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice.

Clin Drug Investig. 2015 Mar;35(3):187-95. doi: 10.1007/s40261-015-0271-0.

Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Thyroid. 2014 Dec;24(12):1670-751. doi: 10.1089/thy.2014.0028.

本文引用的文献

New medications which decrease levothyroxine absorption.

Thyroid. 2007 Aug;17(8):763-5. doi: 10.1089/thy.2007.0060.

Safety considerations with gastrointestinally active lipid-lowering drugs.

Am J Cardiol. 2007 Mar 19;99(6A):47C-55C. doi: 10.1016/j.amjcard.2006.11.022. Epub 2006 Nov 29.

Raloxifene causing malabsorption of levothyroxine.

Arch Intern Med. 2003 Jun 9;163(11):1367-70. doi: 10.1001/archinte.163.11.1367.

Colesevelam hydrochloride.

Am J Health Syst Pharm. 2002 May 15;59(10):932-9. doi: 10.1093/ajhp/59.10.932.

The acute effect of calcium carbonate on the intestinal absorption of levothyroxine.

Thyroid. 2001 Oct;11(10):967-71. doi: 10.1089/105072501753211046.

Effect of calcium carbonate on the absorption of levothyroxine.

JAMA. 2000 Jun 7;283(21):2822-5. doi: 10.1001/jama.283.21.2822.

Sucralfate causes malabsorption of L-thyroxine.

Am J Med. 1994 Jun;96(6):531-5. doi: 10.1016/0002-9343(94)90093-0.

Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide.

Am J Med. 1994 Oct;97(4):363-5. doi: 10.1016/0002-9343(94)90303-4.

The influence of cholestyramine on thyroxine absorption.

JAMA. 1969 Jun 9;208(10):1857-61.

Thyroid hormone and the gut.

Endocr Res. 1988;14(2-3):203-24. doi: 10.3109/07435808809032986.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验